Harman Patil (Editor)

LY 272,015

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
CAS Number
  
172895-15-7

ChemSpider
  
8105055

Molar mass
  
336.426 g/mol

PubChem CID
  
9929424

Formula
  
C21H24N2O2

LY-272,015

Synonyms
  
LY-272,015; 1-[(3,4-Dimethoxyphenyl)methy]-2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indole

LY-272,015 is a beta-carboline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models, and is also used in research into the other functions of the 5-HT2B receptor.

References

LY-272,015 Wikipedia


Similar Topics